AIM ImmunoTech Inc - Company Profile
Powered by 
All the sales intelligence you need on AIM ImmunoTech Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how AIM ImmunoTech Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with AIM ImmunoTech Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
AIM ImmunoTech Inc (AIM ImmunoTech) focuses on the development of new drug therapies for viral and immune-based chronic disorders. The company’s lead product candidate, Ampligen, focuses on R&D activities, and a broad product portfolio is its major strength. However, involvement in legal proceedings remains a major concern for the company. Regulatory approval, a growing market for cancer treatments, and a strategic agreement provide an opportunity to enhance its revenue. However, intense competition, intellectual property risk, and reliance on a few suppliers could hinder its growth in the future.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer